theflyonthewall.com: the Fastest Breaking Financial and Equity News on the Web

News Breaks

06:42 EDT

NKTR

theflyonthewall.com:		Nektar completes enrollment ahead of schedule for phase 2 NKTR-102 trial
		Nektar Therapeutics announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers. :theflyonthewall.com

News For NKTR From The Last 14 Days

Check below for free stories on NKTR the last two weeks.

There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.

February 8, 2010

11:48 EDT

NKTR

theflyonthewall.com:		Nektar management to meet with BMO Capital
		Subscribe for More Information :theflyonthewall.com